Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China

Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China

This study is a prospective, real world study.The objective is to observe the diagnosis and first-line treatment of Chinese patients with cancer of unknown primary, and collect the clinicopathological characteristics, treatment outcomes, survival and other data of the patients.

Inclusion Criteria:

• Had a diagnosis of cancer of unknown primary (CUP) after a standard evaluation .
• Prepared to receive first-line therapy for CUP

Exclusion Criteria:

• Patients who had previously received systemic therapy for CUP
• Previous history of other cancers, except cervix cancer or basal cell carcinoma of the skin that has been cured
• The investigator considered that there were contraindications to treatment or were not appropriate to participate in this study